{"id":"W4410820514","doi":"10.1200/jco.2025.43.16_suppl.7017","title":"Efficacy and safety of first-line ibrutinib plus venetoclax in patients with mantle cell lymphoma (MCL) who were older or had <i>TP53</i> mutations in the SYMPATICO study.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Ibrutinib; Venetoclax; Mantle cell lymphoma; Medicine; Oncology; Internal medicine; Lymphoma; Cancer research; Chronic lymphocytic leukemia; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001184963,0.0005833891,0.001190357,0.0002613614,0.0001803053,0.0005685437,0.0004041585,0.0005103982,0.001318898],"category_scores_gemma":[0.0006743624,0.0002601887,0.001208185,0.0003121711,0.0003216879,0.000484398,0.0003127193,0.00168312,0.000228243],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006154308,"about_ca_system_score_gemma":0.0006819022,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005220738,"about_ca_topic_score_gemma":0.00171691,"domain_scores_codex":[0.9997857,0.00009009829,0.00001487929,0.00003562955,0.00003089533,0.00004279014],"domain_scores_gemma":[0.9994425,0.00009245993,0.0001522047,0.00003385611,0.00002433681,0.000254737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7154748,0.01488059,0.08091311,0.001193114,0.00371639,0.0003867137,0.0003440362,0.002854393,0.0322171,0.0001578404,0.004907669,0.1429543],"study_design_scores_gemma":[0.2857371,0.4475611,0.2488754,0.0001336833,0.003584111,0.001086127,0.000147507,0.002557708,0.003814013,0.0002734263,0.006168675,0.00006116646],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953411,0.002887331,0.0001292427,0.0001422563,0.00004617522,0.0001491755,0.0004962931,0.00001997526,0.0007884273],"genre_scores_gemma":[0.996433,0.001048462,0.0002693701,0.0003239981,0.0001020395,0.0001587209,0.001213633,0.000006137261,0.0004446125],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001318898,"threshold_uncertainty_score":0.006266713,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04735440968525347,"score_gpt":0.4183786760132616,"score_spread":0.3710242663280082,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}